Odyssey Health (ODYY) Other Non-Current Assets (2017 - 2022)
Odyssey Health's quarterly Other Non-Current Assets came in at $366475.0 in Q3 2022, up 747.34% quarter-over-quarter from $43250.0 in Q2 2017.
Odyssey Health has reported Other Non-Current Assets for 2 years, with the latest figure at $366475.0 in Q3 2022.
- For the quarter ending Q3 2022, Other Non-Current Assets changed N/A year-over-year to $366475.0; the trailing twelve-month figure through Jul 2022 stood at $366475.0 (changed N/A YoY), and the FY2022 full-year result was $366475.0, changed N/A from the prior year.
- Other Non-Current Assets for Q3 2022 stood at $366475.0, up from $43250.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $366475.0 in Q3 2022, with the low at $366475.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 140.49 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Odyssey Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2022 | 366,475.00 |
| Apr 30, 2017 | 43,250.00 |
| Jan 31, 2017 | 5.02 Mn |